AOD-9604 was originally developed as a potential anti-obesity drug due to its ability to promote fat loss without significantly impacting muscle growth or insulin levels
lipotropic participates in cellular energy metabolism and is involved in biological pathways studied in healthy-aging research (Covarrubias et al., 2021
For external use on scalp only
Not all GLP-1s are approved for obesity treatment, and this analysis includes all FDA-approved GLP-1s, including those approved for obesity (Saxenda, Weogvy, Zepbound) as well as those approved for type 2 diabetes (see Table 1)
The peptide is establishing its metabolic effects on fat tissue, but the total amount of fat oxidized over just 7-14 days is insufficient to produce measurable body composition changes
$425 COST PER DAY $7.00 6,000 units HCG for 30 days at 200IU per day injections (Includes all supplies needed and a 30 day supply of Hydroxocobalamin B12) Recommended for weight loss up to 20 pounds